Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics of BI 10773 with
repeat dosing for eight days and the exploration of the pharmacokinetics and pharmacodynamics
of BI 10773 after multiple dosing, including dose proportionality and assessment of steady
state.